Eric Gershman MD in Las Vegas, Nevada

Home Nevada Las Vegas

Eric Gershman MD has Hematology/oncology as his primary medical specialty. Their primary office is: 6190 S Fort Apache Rd in Las Vegas, Nevada.

They're a part of the: Robert B. Mcbeath Md Professional Corporation medical group which has around 61 members. You can call their office at 702-724-8787 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Central Del Caribe Escuela De Medicina and graduated in 1986 (around 38 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Eric Gershman MD Office Phone and Directions

Eric Gershman MD
Robert B. Mcbeath Md Professional Corporation
6190 S Fort Apache Rd
Las Vegas, Nevada 89148
702-724-8787

Patient Ratings
Please rate your experience with Eric Gershman MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 702-724-8787

Enter a starting address:

Healthcare Info for Eric Gershman MD

Medical School: University Central Del Caribe Escuela De Medicina
Graduation Year: 1986
The Primary Medical Specialty for Eric Gershman MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 38
PAC (PECOS ID)#: 9032100904
NPI #: 1316903768
NPI Created On: 04/25/2006
NPI Last Updated Listed as: 11/17/2021
Primary Taxonomy Code: 207RH0000X
License Number:
ME55276
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Molina Healthcare of Florida, Inc
Humana
Health Plan of Nevada, Inc.
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.

Services and Procedures include:

Complete blood cell count (red cells, white blood cell, platelets), automated test
Hydration infusion into a vein
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Application of on-body injector for injection under skin
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
Infusion of different chemotherapy drug or substance into a vein up to 1 hour
Therapeutic removal of whole blood to correct blood level imbalance
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Injection, darbepoetin alfa, 1 microgram (non-esrd use)
Injection, denosumab, 1 mg
Injection, dexamethasone sodium phosphate, 1 mg

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $65

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788107093

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788107095

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788107097

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: BALVERSA

Open Associated Drug #1: 59676-030-56

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788107099

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $15

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 789434303

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Opioid Analgesic

Name of Drug #1: XTAMPZA

Open Associated Drug #1: 24510-110-10

Payments Total: $51

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832177815

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832177845

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: ADCETRIS

Open Associated Drug #1: 51144-050-01

Payments Total: $15

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783688547

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ONUREG

Open Associated Drug #1: 59572-730-14

Payments Total: $23

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783688549

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ONUREG

Open Associated Drug #1: 59572-730-14

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 835339523

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: SICKLE CELL DISEASE

Name of Drug #1: OXBRYTA

Open Associated Drug #1: 72786-101-01

Hematology/oncology Professionals in Las Vegas

1.
Holavanahalli Keshava-prasad MD

3730 S Eastern Ave
Las-vegas, NV
Allison Curtis Kingsley Meoz Michael And Sanchez Pc

2.
Foluso Ogunleye

2300 W Charleston Blvd
Las-vegas, NV
Robert B. Mcbeath Md Professional Corporation

3.
Foluso Ogunleye

6190 S Fort Apache Rd
Las-vegas, NV
Robert B. Mcbeath Md Professional Corporation

4.
Edwin Kingsley

3730 S Eastern Ave
Las-vegas, NV
Allison Curtis Kingsley Meoz Michael And Sanchez Pc

5.
Kyaw Thein

3730 S Eastern Ave
Las-vegas, NV
Allison Curtis Kingsley Meoz Michael And Sanchez Pc

6.
Carlos Araujo

2300 W Charleston Blvd
Las-vegas, NV
Robert B. Mcbeath Md Professional Corporation

Providers in Robert B. Mcbeath Md Professional Corporation

1.Darla Adams

2300 W Charleston Blvd
Las Vegas Nv 89102-2149
Robert B. Mcbeath Md Professional Corporation
Nurse Practitioner

2.Carlos Araujo

58 N Pecos Rd
Henderson Nv 89074-7319
Robert B. Mcbeath Md Professional Corporation
Hematology/oncology

3.Carlos Araujo

2300 W Charleston Blvd
Las Vegas Nv 89102-2149
Robert B. Mcbeath Md Professional Corporation
Hematology/oncology

4.Robert Beck

58 N Pecos Rd
Henderson Nv 89074-7319
Robert B. Mcbeath Md Professional Corporation
Radiation Oncology

5.Robert Beck

624 S Tonopah Dr
Las Vegas Nv 89106-4029
Robert B. Mcbeath Md Professional Corporation
Radiation Oncology

6.Robert Beck

3980 S Eastern Ave
Las Vegas Nv 89119-5102
Robert B. Mcbeath Md Professional Corporation
Radiation Oncology

View all 61 members of Robert B. Mcbeath Md Professional Corporation medical group